Clearside Biomedical Inc
CLSD
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.15M
Close$
$1.03
150.8% upside
Current Fair Value
150.8% upsideUndervalued by 150.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.15 Million |
|---|---|
| Enterprise Value | $-4,209,052.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.05 |
| Beta | 1.79 |
| Outstanding Shares | 5,233,981 |
Return
| Return on Equity | 48.19% |
|---|---|
| Return on Assets | -223.31% |
| Return on Invested Capital | -191.48% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.29 |
| Price to Sales | - |
| Price to Book Ratio | -0.04 |
| Enterprise Value to Revenue | -4.21 |
| Enterprise Value to EBIT | 0.25 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.11 |
| Debt to Equity | -0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.52%▼ 9.81% |
|---|---|
| Total Invested | $19,130▼ 99.10% |
| Investors Holding | 1▼ 25.00% |
ESG Score
No data
About Clearside Biomedical Inc
CEO: George Lasezkay